1.Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions.
Bum Kee HONG ; Hyuck Moon KWON ; Byoung Kwon LEE ; Dongsoo KIM ; In Jai KIM ; Seok Min KANG ; Yangsoo JANG ; Sang Ho CHO ; Hae Kyoon KIM ; Byung Chul JANG ; Seung Yun CHO ; Hyun Seung KIM ; Myung Sin KIM ; Hyuck Chan KWON ; Nambo LEE
Yonsei Medical Journal 2000;41(1):82-88
Inflammation appears to have a major role in the development of atherosclerosis. Cyclooxygenase-2 (COX-2) is involved in the inflammatory response via the generation of prostanoids that, in turn, are involved in the production of matrix metalloproteinases (MMPs). This study aimed to investigate atherosclerosis in human aortas for in situ tissue distribution of COX-2, MMPs including MMP-9 and membrane type 1 MMP (MT1-MMP), and tissue inhibitor of metalloproteinase-2 (TIMP-2). Immunohistochemical studies were performed on atherosclerotic lesions of aortas from patients with aortic aneurysms (n = 4) and dissections (n = 3) by using antibodies to COX-2, MMP-9, MT1-MMP, and TIMP-2. Control tissues were obtained from traumatically dissected aortas (n = 2). All specimens from diseased aortas had atherosclerotic lesions ranging from fatty streak to atheromatous plaques. In control, there was no expression of COX-2, MMP-9, and MT1-MMP in all aortic layers. Immunoreactivity for COX-2 was predominantly noted in macrophages and smooth muscle cells (SMCs) of the intima including atherosclerotic plaque itself and the medial layer of the plaque base, as well as in SMCs and endothelial lining of the vasa vasorum in the adventitia. Immunoreactivity for MMP-9 and MT1-MMP was found in the same distribution as that of COX-2. Additionally, the expression of TIMP-2 increased in relation to MMP-9 expression. This study demonstrates that COX-2 is coexpressed with MMP-9 and MT1-MMP, not only by macrophages and SMCs in atherosclerotic lesions, but also in endothelial lining of the vasa vasorum of human aortas. Thus, vascular inflammatory reactions may influence extracellular matrix remodeling by coactivation of MMPs in the development of atherosclerosis and, in turn, the progression of disease.
Animal
;
Aorta/enzymology*
;
Aortic Diseases/pathology
;
Aortic Diseases/enzymology*
;
Arteriosclerosis/pathology
;
Arteriosclerosis/enzymology*
;
Female
;
Guinea Pigs
;
Human
;
Immunochemistry
;
Isoenzymes/metabolism*
;
Male
;
Matrix Metalloproteinases/metabolism*
;
Middle Age
;
Prostaglandin-Endoperoxide Synthase/metabolism*
2.Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: The potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis.
Eui Young CHOI ; Dong Soo KIM ; Bum Kee HONG ; Hyuck Moon KWON ; Young Goo SONG ; Ki Hyun BYUN ; Hyun Young PARK ; Ki Chul WHANG ; Hyun Seung KIM
Experimental & Molecular Medicine 2002;34(6):391-400
Chlamydia pneumoniae infection implicated as an important etiologic factor of atherosclerosis, especially in coronary artery disease (CAD), was found in vitro to be associated with the induction of matrix metalloproteinases (MMPs). An extracellular matrix metalloproteinase inducer (EMMPRIN)/membrane-type 1 matrix metalloproteinase (MT1-MMP) system which induces and activates MMPs,is suggested to be functional and were upregulated in the failing myocardium. However, the upstream regulation of MMPs by C. pneumoniae within atheroma itself remains unclear. We evaluated the seroepidemiologic study of C. pneumoniae infection in CAD patients (n = 391) and controls (n = 97) and performed histopathological and in vitro analysis in atherosclerotic vascular tissues obtained from patients with seropositive to C. pneumoniae (n = 20), by using immunochemistry for C. pneumoniae, EMMPRIN/MT1-MMP, MMP-2, and MMP-9. The seropositive rates of both anti-C. pneumoniae IgG and IgA were 56.7% in CAD group and 43.3% in control group (P =0.033). Seropositive rate was increased in subgroups of CAD patients without conventional coronary risk factors compared to those with conventional risk factors. Immunoreactivities of EMMPRIN, MT1-MMP, MMP-2, and MMP-9 were increased in the atheromatous plaque itself, predominantly in immunoreactive macrophages/mononuclear cells to C. pneumoniae. Furthermore, Western blot analysis showed that EMMPRIN and MMP-2 were detected more prominently in atherosclerotic tissues infected with C. pneumoniae compared to control tissues. Zymographic analysis revealed that activities of MMP-2 and MMP-9 were more increased in atherosclerotic tissues infected with C. pneumoniae compared to control tissues. The present study demonstrated upstream regulation of MMPs can be induced by C. pneumoniae within atheromatous plaque itself. These findings help to understand the potential role of C. pneumoniae in the progression of atherosclerosis.
Aged
;
Animals
;
Arteriosclerosis/complications/enzymology/*microbiology/*pathology
;
Blotting, Western
;
Chlamydia Infections/*complications/enzymology/epidemiology/immunology
;
Chlamydophila pneumoniae/immunology/*pathogenicity
;
Disease Progression
;
Extracellular Matrix/enzymology
;
Female
;
Gelatinases/*metabolism
;
Human
;
Immunohistochemistry
;
Male
;
Matrix Metalloproteinases/*metabolism
;
Membrane Glycoproteins/*metabolism
;
Middle Aged
;
Up-Regulation
3.Genistein Supplementation Inhibits Atherosclerosis with Stabilization of the Lesions in Hypercholesterolemic Rabbits.
Choong Sik LEE ; Su Jin KWON ; Sun Young NA ; Seung Pyung LIM ; Jung Hee LEE
Journal of Korean Medical Science 2004;19(5):656-661
The effect of genistein on aortic atherosclerosis was studied by immunohistochemistry with RAM-11 and HHF-35 antibodies and western blotting for matrix metalloproteinase-3 (MMP-3) in New Zealand White rabbits. After provocation of atherosclerosis with hyperlipidemic diet, the rabbits were divided as hyperlipidemic diet group (HD), normal diet group (ND) and hyperlipidemic plus genistein diet group (HD+genistein) for 4 and half months. The average cross sectional area of atherosclerotic lesion was 0.269 mm2 after provocation. The lesion was progressed by continuous hyperlipidemic diet (10.06 mm2) but was increased mildly by genistein (0.997 mm2), and decreased by normal diet (0.228 mm2). The ratio of macrophages to smooth muscle cells in the lesion was not changed by genistein supplementation. The western blotting showed reduction of MMP-3 expression in HD+genistein and ND groups than HD group. The inhibition of atherogenesis by genistein was might be due to improve the endothelial dysfunction rather than direct action on macrophages and/or smooth muscle cells in the lesion, since endothelial dysfunction by lipid peroxidation was the main atherogenic factor in the hypercholesterolemicrabbits. The genistein supplementation also suggests that it helps the stabilization of the atherosclerotic lesion by inhibition of MMP-3 expression.
Animals
;
Aorta/pathology
;
Arteriosclerosis/*drug therapy/pathology/*prevention & control
;
Blotting, Western
;
Diet, Atherogenic
;
Genistein/*pharmacology
;
Growth Inhibitors/*pharmacology
;
Hypercholesterolemia/*drug therapy/pathology
;
Macrophages/pathology
;
Male
;
Muscle, Smooth, Vascular/enzymology/pathology
;
Rabbits
;
Research Support, Non-U.S. Gov't
;
Stromelysin 1/metabolism
4.Polymorphism of Matrix Metalloproteinase-3 Promoter Gene as a Risk Factor for Coronary Artery Lesions in Kawasaki Disease.
Jeong Ah PARK ; Kyung Sue SHIN ; Youn Woo KIM
Journal of Korean Medical Science 2005;20(4):607-611
Kawasaki disease (KD) is a major cause of acquired coronary artery diseases in childhood. The serum levels of matrix metalloproteinase (MMP)-3 and MMP-9 in KD have been reported to be significantly higher than other diseases. Several studies have demonstrated that MMP-3 5A/6A polymorphism and MMP-9 C-1562T polymorphism modify each transcriptional activity in allele specific manner. We hypothesized that these polymorphisms may play a role as a risk factor for development of coronary artery lesions (CAL) in KD. Eighty-three patients, diagnosed with KD in Cheju National University Hospital from January 2000 to February 2004, were divided into two groups according to the presence of CAL. Genotyping of MMP-3 and MMP-9 gene polymorphisms were determined by restriction fragment length polymorphism. With regard to MMP-3 gene polymorphism, the KD with CAL group had a higher frequency of 6A/6A genotype than control group (p=0.0127) and the KD without CAL group (p=0.0036). However, no significant differences in the allele and genotype distributions of the MMP-9 polymorphism were observed. These findings suggest that MMP-3 6A/6A genotype may be an independent risk factor for CAL formation in KD.
Adolescent
;
Adult
;
Aged
;
Alleles
;
Child
;
Child, Preschool
;
Coronary Arteriosclerosis/enzymology/etiology/*genetics
;
Female
;
Gelatinase B/genetics
;
Gene Frequency
;
Genotype
;
Humans
;
Infant
;
Male
;
Middle Aged
;
Mucocutaneous Lymph Node Syndrome/*complications
;
*Polymorphism, Genetic
;
Promoter Regions (Genetics)/*genetics
;
Research Support, Non-U.S. Gov't
;
Risk Factors
;
Stromelysin 1/*genetics
5.Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro.
Hyun Young PARK ; Hyuck Moon KWON ; Hyun Joung LIM ; Bum Kee HONG ; Ju Yong LEE ; Byoung Eun PARK ; Yang Soo JANG ; Seung Yun CHO ; Hyun Seung KIM
Experimental & Molecular Medicine 2001;33(2):95-102
Leptin, the product of ob gene, is an endocrine hormone that regulates adipose tissue mass. Recently, leptin has been found to generate a growth signal involving a tyrosine kinase-dependent intracellular pathway and promote angiogenic processes via activation of leptin receptor (Ob-R) in endothelial cells. However, it is not clear how leptin functions to promote multi-step processes involved in the neovascularization at the atherosclerotic plaque. We have examined the expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) and Ob-R in human atherosclerotic lesions, leptin-mediated angiogenesis in vivo and in vitro. Immunohistochemical analysis of human atherosclerotic aorta revealed an increased expression of Ob-R in the intima of neorevascularized regions and of both MMPs and TIMPs predominantly in the endothelial lining of intimal neovessels and macrophages/foam cells. In the rat corneal angiogenesis assay, leptin elicited a comparable sensitivity of angiogenic activity to those of vascular endothelial growth factor (VEGF). The immunohistological analysis of the leptin-treated rat cornea showed definitive rises in Ob-R, MMPs and TIMPs expression as well as those of VEGF receptor (VEGFR-1). Leptin (10-40 ng/ml) induced proliferation of the human umbilical vein endothelial cells (HUVECs) and elevation of MMP-2, MMP-9, TIMP-1, and TIMP-2 expression in a dose-dependent manner. Leptin also induced increases of MMP-2, MMP-9, TIMP-1, and Up-regulated the human coronary artery smooth muscle cells (HCASMCs). These findings suggest that leptin, a hormone with pluralistic properties including a mitogenic activity on vascular endothelial cells, plays a role in matrix remodeling by regulating the expression of MMPs and TIMPs. Taken together, our findings further provide evidences for leptin's role as an angiogenesis inducer in the normal organ (rat cornea) and in aberrant vasculature under duress like atherosclerosis.
Animal
;
Arteriosclerosis/metabolism
;
Blotting, Western
;
Cell Division
;
Cells, Cultured
;
Dose-Response Relationship, Drug
;
Endothelial Growth Factors/metabolism
;
Endothelium, Vascular/*cytology/*enzymology
;
Enzyme-Linked Immunosorbent Assay
;
Fibroblast Growth Factor 2/metabolism
;
Immunohistochemistry
;
Leptin/*chemistry/metabolism/*physiology
;
Lymphokines/metabolism
;
Matrix Metalloproteinases/*biosynthesis
;
*Neovascularization, Pathologic
;
Rats
;
Receptor Protein-Tyrosine Kinases/metabolism
;
Receptors, Growth Factor/metabolism
;
Recombinant Proteins/metabolism
;
Support, Non-U.S. Gov't
;
Tissue Inhibitor of Metalloproteinases/metabolism
;
Umbilical Veins/metabolism
;
Up-Regulation